Literature DB >> 10462222

Oxidative myocytes of heart and skeletal muscle express abundant sarcomeric mitochondrial creatine kinase.

W Qin1, Z Khuchua, J Boero, R M Payne, A W Strauss.   

Abstract

Sarcomeric mitochondrial creatine kinase catalyzes the reversible transfer of a high energy phosphate between ATP and creatine. To study cellular distribution of the kinase, we performed immunocytochemical studies using a peptide antiserum specific for the kinase protein. Our results demonstrated that the sarcomeric mitochondrial creatine kinase gene is abundantly expressed in heart and skeletal muscle, with no protein detected in other tissues examined, including brain, lung, liver, spleen, kidney, bladder, testis, stomach, intestine, and colon. RNA blot study showed that there is no detectable expression of the kinase mRNA in the thymus gland. In heart and skeletal muscle, the kinase protein is expressed in atrial and ventricular cardiomyocytes and a subpopulation of skeletal myofibres. In skeletal muscle, fast myosin heavy chain co-localization studies demonstrated that the sarcomeric mitochondrial creatine kinase is highly expressed in type 1, slow-oxidative and type 2A, fast-oxidative-glycolytic myofibres. We conclude that the kinase gene is abundantly expressed in oxidative myocytes of heart and skeletal muscle and may contribute to oxidative capacity of these cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462222     DOI: 10.1023/a:1003748108062

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  2 in total

Review 1.  Structural and functional adaptations of striated muscles to CK deficiency.

Authors:  R Ventura-Clapier; A Kaasik; V Veksler
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

2.  Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles.

Authors:  A Garnier; D Fortin; C Deloménie; I Momken; V Veksler; R Ventura-Clapier
Journal:  J Physiol       Date:  2003-06-24       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.